Metformin vs semaglutide: semaglutide (Ozempic, Rybelsus, Wegovy) lowers blood sugar and weight considerably more than metformin, while metformin is a low-cost generic pill with decades of use. In their own placebo-controlled trials, metformin lowered HbA1c by 1.4 points (versus a 0.4-point rise on placebo), and semaglutide 1 mg by about 1.5 points with 4.5 kg of weight loss.[1][4] They are not rivals in practice: most semaglutide trials enrolled people already taking metformin, and the two are often used together.[5]
See our semaglutide profile for the drug’s background.
Metformin vs semaglutide at a glance
| Metformin | Semaglutide | |
|---|---|---|
| Drug class | Biguanide[1] | GLP-1 receptor agonist[2] |
| Form | Tablets, once to three times daily[1] | Weekly injection or daily tablet[2][12] |
| Approved for | Type 2 diabetes, ages 10+[1] | Type 2 diabetes (Ozempic, Rybelsus); weight and heart risk (Wegovy)[2][3] |
| HbA1c drop in placebo trial | −1.4 vs +0.4 (29 weeks)[1] | −1.45 to −1.55 vs −0.02 (30 weeks)[4] |
| Weight effect | About −2% (DPP)[7] | −14.9% at 2.4 mg in obesity (STEP 1)[8] |
| Heart-outcome benefit on label | No | Yes[2][12] |
| Main side effects | Diarrhea, nausea, gas[1] | Nausea, diarrhea, vomiting, constipation[2] |
| Boxed warning | Lactic acidosis[1] | Thyroid C-cell tumors in rodents[2] |
| Generic | Yes, many makers[1] | No US generic |
How they work
- Metformin mainly lowers the amount of glucose the liver releases and improves the body’s response to insulin. It does not raise insulin levels on its own, so it rarely causes low blood sugar when used alone.[1]
- Semaglutide copies the gut hormone GLP-1. It increases insulin release when blood sugar is high, lowers glucagon, slows stomach emptying and reduces appetite.[2]
Because they act differently, their effects add up when used together.
Blood sugar control
Metformin and semaglutide have never been compared head to head as first treatments. Their placebo-controlled trials give a rough picture:
| Trial | Drug | Weeks | HbA1c change | Placebo |
|---|---|---|---|---|
| US label trial | Metformin up to 2,550 mg/day | 29 | −1.4[1] | +0.4 |
| SUSTAIN 1 | Semaglutide 0.5 / 1 mg weekly | 30 | −1.45 / −1.55[4] | −0.02 |
| PIONEER 1 | Oral semaglutide 7 / 14 mg | 26 | −1.2 / −1.4[12] | −0.3 |
The metformin trial started from a higher average blood sugar, which tends to produce larger drops, so the numbers are not directly comparable.[1][4]
Weight loss
Weight is where the two differ most.
- Metformin: in the Diabetes Prevention Program, people with prediabetes on metformin lost about 2.1% of their weight versus almost none on placebo, and kept a 2% loss for years if they stayed on it.[7] In the label’s diabetes trial, weight barely changed.[1]
- Semaglutide in diabetes: semaglutide 1 mg lowered weight by about 4.5 kg in SUSTAIN 1 and 6.5 kg in SUSTAIN 7.[4][5] At the Wegovy dose of 2.4 mg, people with type 2 diabetes lost 9.6% in STEP 2.[9]
- Semaglutide without diabetes: 14.9% at 2.4 mg in STEP 1.[8]
Metformin is not approved for weight loss.[1]
Preventing diabetes
Metformin has long-term prevention data. In the Diabetes Prevention Program, it reduced new cases of type 2 diabetes by 31% compared with placebo over about 3 years, while an intensive lifestyle program reduced them by 58%.[6] Semaglutide is not approved to prevent diabetes, although weight loss itself lowers risk.
Heart and kidney protection
Semaglutide has outcome trials: in SUSTAIN-6, heart attack, stroke or cardiovascular death fell from 8.9% to 6.6% in people with type 2 diabetes at high risk, and in SOUL oral semaglutide lowered these events from 13.8% to 12.0%.[10][11] Ozempic also has a kidney-protection indication.[2] Metformin’s label does not include a heart or kidney indication.[1]
Side effects and safety
- Metformin: diarrhea, nausea or vomiting, gas and indigestion are the most common side effects. It can lower vitamin B12 over time. Its boxed warning covers lactic acidosis, a rare but serious build-up of acid, with higher risk in kidney impairment; it should not be used if eGFR is below 30.[1]
- Semaglutide: nausea, vomiting, diarrhea and constipation, mostly while increasing the dose; warnings include pancreatitis, gallbladder problems and diabetic eye complications.[2]
- Low blood sugar: neither usually causes it alone, but the risk rises when either is combined with insulin or a sulfonylurea.[1][2]
In the long-term DPP follow-up, metformin’s stomach side effects were more common than placebo early on and declined over time.[7]
Taking metformin and semaglutide together
Combining them is standard practice. In SUSTAIN 7, every participant was on metformin when semaglutide was added; in SOUL, 76% were on metformin.[5][12]
Practical points: both can cause stomach upset, so starting them at the same time can add side effects. Many clinicians keep metformin when adding semaglutide; any change is your prescriber’s decision.
Dosing compared
Metformin tablets usually start at 500 mg twice a day or 850 mg once a day with meals, increasing gradually to as much as 2,550 mg a day; taking it with food and raising the dose slowly helps limit stomach upset. Kidney function is checked before starting.[1] Ozempic starts at 0.25 mg once a week, which is a starting step rather than a treatment dose, and rises every 4 weeks toward 0.5, 1 or 2 mg.[2] Rybelsus tablets start at 3 mg daily for 30 days and must be taken on an empty stomach.[12] Your prescriber sets the dose for each.
Which is right for you?
- New diabetes, cost is a concern, no heart or kidney disease: metformin is a common, inexpensive starting point.
- Heart disease, kidney disease or obesity alongside diabetes: semaglutide adds proven heart benefit and, as Ozempic, kidney protection.[2][10]
- Weight loss without diabetes: metformin is not approved for this; semaglutide is, as Wegovy.[1][3]
- Kidney function below an eGFR of 30: metformin should not be used.[1]
Cost
Metformin is available as low-cost generics from many manufacturers.[1] Semaglutide has no US generic. In October 2026, NovoCare listed self-pay Ozempic at $349 a month for most doses and $499 for 2 mg.[14] See semaglutide cost for insurance and savings options.
Prices checked October 2026. They change often; confirm with your pharmacy or plan.
